Cargando…

Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review

Endometrial cancer is the most common female genital tract cancer in developed countries. We systematically reviewed the current health-economic evidence on early detection and prevention strategies for endometrial cancer based on a search in relevant databases (Medline/Embase/Cochrane Library/CRD/E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sroczynski, Gaby, Gogollari, Artemisa, Conrads-Frank, Annette, Hallsson, Lára R., Pashayan, Nora, Widschwendter, Martin, Siebert, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408795/ https://www.ncbi.nlm.nih.gov/pubmed/32664613 http://dx.doi.org/10.3390/cancers12071874

Ejemplares similares

Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations
por: Hallsson, Lára R., et al.
Publicado: (2023)

Decision-analytic modeling for early health technology assessment of medical devices – a scoping review
por: Conrads-Frank, Annette, et al.
Publicado: (2022)

Vergleich der Effektivität von multiplen dynamischen Behandlungsstrategien unter Nutzung der Target-Trial-Emulierung: Kontrafaktischer Ansatz zur Kausalinferenz aus Real-World-Daten
por: Kuehne, Felicitas, et al.
Publicado: (2023)

The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany
por: Schaffner, Monika, et al.
Publicado: (2020)

Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model(®) for Rapid Relative Effectiveness Assessment
por: Stürzlinger, Heidi, et al.
Publicado: (2023)

Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment
por: Siebert, Uwe, et al.
Publicado: (2003)

Causal evidence in health decision making: methodological approaches of causal inference and health decision science
por: Kühne, Felicitas, et al.
Publicado: (2022)

Pharmacogenomics Bias - Systematic distortion of study results by genetic heterogeneity
por: Siebert, Uwe, et al.
Publicado: (2008)

Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia
por: Vukićević, Đurđa, et al.
Publicado: (2020)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
por: Mühlberger, Nikolai, et al.
Publicado: (2009)

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online
por: Jahn, Beate, et al.
Publicado: (2017)

Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants
por: Seidl, Astrid, et al.
Publicado: (2018)

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR
por: Hoffmann, Sabine, et al.
Publicado: (2020)

Prevention in the age of personal responsibility: epigenetic risk-predictive screening for female cancers as a case study
por: Bolt, Ineke, et al.
Publicado: (2021)

An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply
por: Bicher, Martin, et al.
Publicado: (2022)

Personalized early detection and prevention of breast cancer: ENVISION consensus statement
por: Pashayan, Nora, et al.
Publicado: (2020)

Women’s perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey
por: Wegwarth, Odette, et al.
Publicado: (2019)

Do cancer risk and benefit–harm ratios influence women’s consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries
por: Rebitschek, Felix G., et al.
Publicado: (2019)

DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
por: Herzog, Chiara, et al.
Publicado: (2022)

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany
por: Sroczynski, Gaby, et al.
Publicado: (2010)

Occupational therapy for persons with cognitive impairments
por: Schnell-Inderst, Petra, et al.
Publicado: (2023)

Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer
por: O’Mara, Tracy A., et al.
Publicado: (2020)

Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria
por: Jahn, Beate, et al.
Publicado: (2019)

Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model
por: Mühlberger, Nikolai, et al.
Publicado: (2017)

Prevention Strategies in Endometrial Carcinoma
por: MacKintosh, Michelle L., et al.
Publicado: (2018)

Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria
por: Jahn, B., et al.
Publicado: (2015)

Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility
por: Pashayan, Nora, et al.
Publicado: (2006)

Sex-specific genetic variances in life-history and morphological traits of the seed beetle Callosobruchus maculatus
por: Hallsson, Lára R, et al.
Publicado: (2012)

Cost effectiveness of the NHS breast screening programme: life table model
por: Pharoah, Paul D P, et al.
Publicado: (2013)

The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023)

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
por: Pashayan, Nora, et al.
Publicado: (2018)

Predictive accuracy of combined genetic and environmental risk scores
por: Dudbridge, Frank, et al.
Publicado: (2017)

Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
por: Christensen, Kurt D., et al.
Publicado: (2015)

Hormones and breast and endometrial cancers: preventive strategies and future research.
por: Hulka, B S, et al.
Publicado: (1995)

The WID‐qEC test: Performance in a hospital‐based cohort and feasibility to detect endometrial and cervical cancers
por: Schreiberhuber, Lena, et al.
Publicado: (2022)

Upstream Statin Therapy and Long-Term Recurrence of Atrial Fibrillation after Cardioversion: A Propensity-Matched Analysis
por: Fiedler, Lukas, et al.
Publicado: (2021)

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
por: Callender, Thomas, et al.
Publicado: (2021)

P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study
por: Jahn, B., et al.
Publicado: (2022)

Feasibility, Safety, and Cost Outcomes of Laparoscopic Management of Early Endometrial and Cervical Malignancy
por: Hilaris, Georgios E., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fdkcdrpderskoh33pk5uml5hm7